Clinical Trial Update: Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab [NA]

View source ↗

Summary

A real-world study of relapsed/refractory multiple myeloma patients treated with isatuximab is currently recruiting, sponsored by Pack Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Isatuximab (isatuximab)

Snippet

Sponsor: Pack Health | Conditions: Multiple Myeloma, Refractory Multiple Myeloma | NA | Status: RECRUITING